MBA501 Presentation: Dynamic Strategy & Disruptive Innovation

This presentation provides an analysis of dynamic strategy and disruptive innovation within the context of the FutureMed case study, a radiopharmaceuticals company. It examines the internal, external, marketing, and technological perspectives influencing the organization's innovative capacity. The internal perspective highlights the need for a systematic approach to identify and develop disruptive technologies, emphasizing clinical research methods and clean room facilities. The marketing perspective focuses on value-based reimbursement and the potential for instrumental molecular imaging to enhance product marketing and clinical care. The technological perspective underscores the importance of investing in positron emission tomography and computed tomography technologies, recommending the launch of cadmium zinc telluride whole body SPECT and innovations in disease diagnosis. The external perspective addresses employee resistance to change and the challenges of introducing products to the market, suggesting the application of the Christensen model of disruptive technology. The presentation concludes with recommendations for FutureMed to enhance its innovative capacity and capitalize on emerging market opportunities.